kyotorphin has been researched along with Anxiety in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angelova, H; Dzhambazova, E; Kostadinova, N; Krumova, E; Landzhov, B; Miteva-Staleva, J; Pechlivanova, D | 1 |
| Angelova, H; Dzhambazova, E; Krumova, E; Pechlivanova, D | 1 |
2 other study(ies) available for kyotorphin and Anxiety
| Article | Year |
|---|---|
Moderate protective effect of Kyotorphin against the late consequences of intracerebroventricular streptozotocin model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Anxiety; Brain; Disease Models, Animal; Endorphins; Male; Motor Activity; Neuroprotective Agents; Rats; Rats, Wistar; Spatial Memory; Streptozocin; Treatment Outcome | 2019 |
Effects of the antinociceptive dipeptide L-tyrosine-L-arginine (kyotorphin) on the motivation, anxiety, and memory in rats.
Topics: Analgesics; Animals; Anxiety; Arginine; Dipeptides; Endorphins; Male; Motivation; Rats; Rats, Wistar; Tyrosine | 2021 |